GO:0004722 protein serine/threonine phosphatase activity

Protein serine/threonine phosphatases (PSPs) are a class of enzymes that catalyze the removal of phosphate groups from serine or threonine residues on target proteins, a process that is fundamental to cellular signal transduction. This enzymatic activity, classified under the Gene Ontology term GO:0004722, counteracts the action of protein kinases and is essential for maintaining the dynamic equilibrium of protein phosphorylation in eukaryotic cells. Dysregulation of PSP activity has been linked to a wide range of human pathologies, including cancer, neurodegenerative disorders, and infectious diseases. Understanding the molecular mechanisms, regulatory networks, and substrate specificities of these enzymes is therefore a major focus of biomedical research. The PSP superfamily comprises several distinct families, including protein phosphatase 1 (PP1), protein phosphatase 2A (PP2A), protein phosphatase 2B (PP2B/calcineurin), and protein phosphatase 2C (PP2C), each characterized by unique structural features and regulatory mechanisms. These enzymes are not merely passive housekeeping proteins; they are tightly regulated by a myriad of interacting subunits, post-translational modifications, and small molecule inhibitors. For instance, PP2A is regulated by tyrosine phosphorylation, which modulates its catalytic activity and substrate specificity. Such regulatory complexity underscores the importance of precise experimental models to study PSP function in health and disease. Recent advances in CRISPR gene editing have revolutionized the study of PSPs by enabling the generation of knockout, point-mutant, and knock-in cell and animal models. These tools allow researchers to interrogate the specific roles of individual phosphatase genes and their regulatory subunits in cellular processes and disease phenotypes. This article provides a comprehensive overview of GO:0004722, covering its definition, molecular mechanisms, key genes, disease associations, and state-of-the-art research methods, with a focus on how CRISPR-based models can accelerate discovery in this field.

GO:0004722, protein serine/threonine phosphatase activity, is defined as the catalysis of the reaction: protein serine phosphate + H2O = protein serine + phosphate, and protein threonine phosphate + H2O = protein threonine + phosphate. In other words, it is the enzymatic activity that removes phosphate groups from serine or threonine residues on proteins, using water as a nucleophile. This activity is fundamental to the reversal of protein kinase signaling and is carried out by a diverse group of enzymes known as protein serine/threonine phosphatases.

Protein serine/threonine phosphatase activity is critically important because it provides the essential counterbalance to protein kinase signaling, thereby controlling virtually all cellular processes, including cell cycle progression, apoptosis, metabolism, and differentiation. Dysregulation of this activity is associated with numerous human diseases, such as cancer, where altered phosphatase activity can promote uncontrolled proliferation, and neurodegenerative disorders, where impaired dephosphorylation contributes to protein aggregation. Moreover, serine/threonine phosphatases are targets of natural toxins and are exploited by pathogens, as seen in Bacillus anthracis and Leishmania mexicana. Understanding this activity is therefore fundamental to both basic biology and therapeutic development.

The following table lists key genes encoding protein serine/threonine phosphatases and their regulatory subunits, along with their major roles and research relevance.

Protein serine/threonine phosphatase activity is regulated at multiple levels. Regulatory subunits dictate substrate specificity, subcellular localization, and catalytic activity. Post-translational modifications, such as phosphorylation of the catalytic subunit, can directly modulate activity; for example, tyrosine phosphorylation of PP2A regulates its phosphatase activity. Small molecule inhibitors, including okadaic acid, cantharidin, and microcystin, bind to the catalytic site and inhibit activity. Additionally, endogenous inhibitor proteins such as I-1 and I-2 regulate PP1 activity in response to signaling cascades. In pathogens, phosphatase activity is regulated during life cycle transitions, as seen in Bacillus anthracis.

Dysregulation of serine/threonine phosphatases is frequently observed in cancer. PP2A is considered a tumor suppressor, and its inactivation by mutation or post-translational modification contributes to oncogenesis. For example, tyrosine phosphorylation of PP2A inhibits its activity, promoting cell proliferation. Other phosphatases, such as PPM1D, are oncogenic and amplified in certain tumors. Targeting these phosphatases is a promising therapeutic strategy.

Impaired serine/threonine phosphatase activity has been implicated in neurodegenerative diseases such as Alzheimer's and Parkinson's. Leucine-rich repeat kinase 2 (LRRK2), a kinase linked to Parkinson's disease, is regulated by phosphatases, and its dysfunction leads to altered phosphorylation of substrates. PP2A dysfunction contributes to tau hyperphosphorylation, a hallmark of Alzheimer's disease.

Pathogens exploit serine/threonine phosphatases for virulence. In Leishmania mexicana, PP2C is essential for survival within macrophages and for stress response. In Bacillus anthracis, the PrpN phosphatase regulates spore formation and toxin production, making it a potential target for anti-infective strategies.

Direct measurement of serine/threonine phosphatase activity is typically performed using colorimetric or fluorometric assays with synthetic phosphopeptide substrates. These assays can be used to assess the effect of mutations, inhibitors, or regulatory subunits on catalytic activity.

Mass spectrometry-based phosphoproteomics allows global profiling of phosphorylation changes upon modulation of phosphatase activity. This approach can identify novel substrates and signaling pathways regulated by specific phosphatases.

Genome-wide CRISPR knockout or activation screens can identify genes that modulate phosphatase activity or confer resistance to phosphatase inhibitors. Such screens are powerful for discovering synthetic lethal interactions and drug targets.

X-ray crystallography and cryo-EM have provided detailed insights into the catalytic mechanism and regulatory subunit interactions of serine/threonine phosphatases. These structures guide the design of specific inhibitors and mutations.

Researchers studying protein serine/threonine phosphatase activity-related genes often need to determine whether a candidate gene is causally involved in a specific biological process or disease. This requires precise genetic models that can knockout, mutate, or overexpress the gene of interest in relevant cell types. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate such studies.

Protein serine/threonine phosphatase activity (GO:0004722) is a cornerstone of cellular signaling, counterbalancing kinase activity and controlling diverse physiological processes. Its dysregulation is implicated in cancer, neurodegeneration, and infectious diseases, making it a prime target for therapeutic intervention. Advances in CRISPR gene editing have provided powerful tools to study these enzymes with unprecedented precision. EDITGENE offers a full range of CRISPR services to support researchers in uncovering the roles of serine/threonine phosphatases in health and disease.